OCONUS Hematology Support
Closed Solicitation Posted
- Solicitation number
- W9114F25QA018
- Agency
- Medical Command Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Landstuhl Rhineland-Palatinate Germany
- Points of contact
-
- Henning Mayer-Goldstein henningfalk.mayer-goldstein.ln@health.mil +49637194646789
- Matthew Elden matthew.r.elden.civ@health.mil +49636194645252
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking a contractor to provide comprehensive hematology support services for eight U.S. military medical facilities located in Germany, including locations in Wiesbaden, SHAPE, Grafenwoehr, Hohenfels, Ansbach, Vilseck, Stuttgart, and the Armed Services Blood Bank Center-Europe. The solicitation is for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with Firm-Fixed Prices, structured on a Cost Per Reportable Result (CPRR) basis, and will be awarded through full and open competition. Contractors must provide FDA-approved hematology analyzer systems, installation, maintenance, reagents, supplies, and consumables, with a requirement to submit technical capability documentation limited to 50 pages and past performance evidence. The government intends to evaluate and award the contract without discussions, with quotes due by February 27, 2025. A post-award conference is scheduled for March/April 2024, with a minimum guaranteed payment of EUR 1,000.
The contract opportunity is not set aside for any specific business category and will cover a 53-month period from May 1, 2025, to September 30, 2029. The estimated reportable results range from 5,300 to 15,900 per location, with the contractor responsible for comprehensive service, maintenance, data security, and compliance with DoD cybersecurity requirements. Performance will be primarily at Landstuhl, Germany, with the contractor bearing all costs associated with potential data breaches. The solicitation falls under NAICS Category 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC Category 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. Key contractual obligations include providing monthly standing orders for reagents with 24-hour emergency delivery, conducting method verification studies per College of American Pathologist standards, and delivering initial and ongoing operator training.
Notice text
This combined synopsis/solicitation is for Hematology Support for the below listed locations on a Cost Per Reportable Result (CPRR) basis. The supplies contemplated have been determined to be commercial in nature. The resultant contract type will be an Indefinite Delivery, Indefinite Quantity (ID/IQ) contract type with Firm-Fixed Prices (FFP) line items. The solicitation is issued for full and open competition. It is incumbent upon interested parties to review this site frequently for any updates/amendments to any and all documents.
Contract Period: 1 May 2025 - 30 September 2029
See attachments for details.
Attachments
| File | Type | Posted |
|---|---|---|
| Projected Implementation Plan.pdf | ||
| Solicitation - W9114F25QA018.pdf | ||
| Contract Requirements .pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity